Download PDF
Nuklearmedizin 1972; 11(03): 247-253
DOI: 10.1055/s-0038-1624789
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Possibilities of Scintigraphic Detection of Tumours and Damaged Tissues with the Aid of Radioactive Mercury Compounds

Möglichkeiten der szintigraphischen Diagnose von Tumoren und geschädigtem Gewebe mittels radioaktiver QuecksilberverbindungenLes possibilitées de la détection scintigraphique de tumeurs et de dissues endomagés à l’aide de composés du mercure radioactive
I. Petrboková
1   Research Unit of Nuclear Medicine (Head: Doc. MuDr. B. Vavrejn CSc) of the Institute for Clinical and Experimental Medicine (Director: Prof. MuDr. P. Mdlek, Dr Sc.) Praha
,
B. Vavrejn
1   Research Unit of Nuclear Medicine (Head: Doc. MuDr. B. Vavrejn CSc) of the Institute for Clinical and Experimental Medicine (Director: Prof. MuDr. P. Mdlek, Dr Sc.) Praha
,
L. Kronrád
› Author Affiliations
Further Information

Publication History

Received:29 May 1972

Publication Date:
15 January 2018 (online)

    Permissions and Reprints

Die Speicherung von 197Hg-Quecksilbercysteinide wurde in vier Arten von experimentellen Tumoren untersucht. Die Ergebnisse zeigten keine höhere Tumorspeicherung im Vergleich zum 197Hg-Quecksilbertetracycline oder 197Hg-Quecksilberazetat. Die Möglichkeit einer Verwendung von 197Hg-cysteinid zur Diagnose eines Herzinfarktes wurde bestätigt.

Summary

The accumulation of mercury cysteinide-197Hg in four types of experimental tumours has been studied. The results have not shown any significantly higher accumulation in tumours than that of mercury tetracycline-197Hg.

The possibility of utilizing cysteinide-197Hg for detecting myocardial infarction was verified.

On a étudié l’accumulation du cysteinide197Hg chez les 4 types des tumeurs artificielles. On n’a pas trouvé la différence significative dans le degré d’accumulation en comparant le tetracycline197Hg avec l’acetate197Hg.

En même temps on a attesté la possibilité d’utilisation du cysteinide197Hg pour la détermination d’infarcte du myocarde.

 

  • References

  • 1 Blau H., Bender A. Radiomercury (203Hg) labeled neohydrin: a new agent for brain tumour localization. J. nucl. Med. 1962; 3: 83-85.
    Google Scholar
  • 2 Farah A., Kruse R. The relation of mercurial diuresis to cellular protein-bound sulfhydryl changes in renal cells. J. Pharmacol, exp. Ther. 1960; 130: 13-19.
    PubMedGoogle Scholar
  • 3 Kotsilimbas D. G., Scheinberg L. C. Chlormerodrin 203Hg and electrolyte distribution in murine brain tumours. Arch. Neurol. (Chic.) 1965; 13: 525-532.
    CrossrefPubMedGoogle Scholar
  • 4 Kronrád L., Petrboková I., Vavrejn B. Distribution and behaviour of various labelled mercury compounds in the organism. I. Distribution of mercuritetracycline, mercuric acetate and chlormerodrin in rats. In press
    Google Scholar
  • 5 Kronrad L., Petrboková I., Vavrejn B. A comparison of the distribution of mercury and cadmium complexes with cystein in rats (and mice). To be published
    Google Scholar
  • 6 Málek P., Vavrejn B., Ratuský J., Kronrád L., Kolc J. Geschwindigkeit der selektiven Akkumulation von mercurascan-203Hg in geschädigten Muskeln und im ischämischen Myokard. Experientia 1967; 23: 649-653.
    CrossrefPubMedGoogle Scholar
  • 7 Morello F., Giordano G. P., Alvisi C., Sciascia R. Scintiscanning of cerebral neoplasm by radioactive mercury (Neohydrin 203Hg). Acta radiol. (Stockholm) 1966; 5: 884-889.
    Google Scholar
  • 8 Overton M. C., Haynie T. P., Olle W. K. , Beentjes L. B. The relationship of isotope concentration and tumour size to detectibility by brain scanning with radiomercury. Tex. Rep. Biol. Med. 1966; 24: 112-124.
    PubMedGoogle Scholar
  • 9 Petrboková I., Kronrád L., Vavrejn B. Distribution and behaviour of various labelled mercury compounds in the organism. II. Change in the distribution of mercerized tetracycline in rats as a function of the applied amount. In press
    Google Scholar
  • 10 Rymer H., Isaac R., Raynaud C., Kellershohn C., Monod O. Scintigraphies pulmonaries au mercure radioactif. J. franç. Méd. Chir. thor. 1967; 21: 129-140.
    PubMedGoogle Scholar
  • 11 Sklaroff D., Polakoff P. P. Cerebral scanning with radioactive chlormerodrin (Neohydrin). Neurology 1963; 13: 79.
    CrossrefPubMedGoogle Scholar
  • 12 Vavrejn B., Kronrád L., Petrboková I. Distribution and behaviour of various labelled mercury compounds in the organism. III. Accumulation of mercuritetracycline, mercuric acetate, and chlormerodrin in damaged muscle and tumour. In press
    Google Scholar
  • 13 Weiner I. M., Levy R. I., Mudge G. H. Studies on mercurial diuresis. Renal excretion, acid stability and structure activity relationship of organic mercurials. J. Pharmacol
    Google Scholar